Vifor Fresenius Medical Care Renal Pharma Ltd

General

Total Cases8
Active Cases1
Patents16
CourtsD. Delaware
TypeOperating Company
Elite Ratings
--
--
--
--

Ratings

Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
08/10/23
Vifor Fresenius Medical Care Renal Pharma Ltd v. Aurobindo Pharma Ltd
1:23-CV-00877
 (
D. DE
)
Summons Issued as to Aurobindo Pharma USA, Inc. on 8/10/2023. (jfm) (Entered: 08/10/2023)
08/10/23
Vifor Fresenius Medical Care Renal Pharma Ltd v. Aurobindo Pharma Ltd
1:23-CV-00877
 (
D. DE
)
Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate CSL Limited, Other Affiliate Vifor Pharma AG, Other Affiliate Fresenius Medical Care AG & Co. KGaA, Other Affiliate Vifor Pharma Participations AG, Other Affiliate CSL Vifor Group, Other Affiliate CSL Behring AG, Other Affiliate CSL Behring Holdings Limited, Other Affiliate Behrin (Holdings) Pty Ltd. for Vifor Fresenius Medical Care Renal Pharma France S.A.S., Vifor Fresenius Medical Care Renal Pharma Ltd. filed by Vifor Fresenius Medical Care Renal Pharma France S.A.S., Vifor Fresenius Medical Care Renal Pharma Ltd. (jfm) (Entered: 08/10/2023)
08/10/23
Vifor Fresenius Medical Care Renal Pharma Ltd v. Aurobindo Pharma Ltd
1:23-CV-00877
 (
D. DE
)
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) see attached. (jfm) (Entered: 08/10/2023)
08/10/23
Vifor Fresenius Medical Care Renal Pharma Ltd v. Aurobindo Pharma Ltd
1:23-CV-00877
 (
D. DE
)
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: Vifor Fresenius Medical Care Renal Pharma Ltd. on July 4, 2023, and Vifor Fresenius Medical Care Renal Pharma France S.A.S. on June 28, 2023. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 1/4/2026. (jfm) (Entered: 08/10/2023)
08/10/23
Vifor Fresenius Medical Care Renal Pharma Ltd v. Aurobindo Pharma Ltd
1:23-CV-00877
 (
D. DE
)
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 08/10/2023)
08/10/23
Vifor Fresenius Medical Care Renal Pharma Ltd v. Aurobindo Pharma Ltd
1:23-CV-00877
 (
D. DE
)
COMPLAINT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Filing fee $ 402, receipt number ADEDC-4198807.) - filed by Vifor Fresenius Medical Care Renal Pharma Ltd., Vifor Fresenius Medical Care Renal Pharma France S.A.S. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Civil Cover Sheet)(jfm) (Entered: 08/10/2023)
02/07/23
Vifor Fresenius Medical Care Renal Pharma Ltd v. Lupin Atlantis Holdings SA
1:18-CV-00390
 (
D. DE
)
USCA Order Terminating Appeal as to 332 Notice of Appeal (Federal Circuit) filed by Teva Pharmaceuticals USA, Inc.. USCA Decision: Appeal Dismissed. (mdb) (Entered: 02/07/2023)
02/07/23
Vifor Fresenius Medical Care Renal Pharma Ltd v. Teva Pharma USA Inc
1:22-CV-01227
 (
D. DE
)
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Stipulation of Dismissal)(mdb) (Entered: 02/07/2023)
02/06/23
Vifor Fresenius Medical Care Renal Pharma Ltd v. Teva Pharma USA Inc
1:22-CV-01227
 (
D. DE
)
SO ORDERED re 17 Stipulation of Dismissal. ***Civil Case Terminated. Signed by Judge Maryellen Noreika on 2/6/2023. (dlw) (Entered: 02/06/2023)
02/06/23
Vifor Fresenius Medical Care Renal Pharma Ltd v. Teva Pharma USA Inc
1:22-CV-01227
 (
D. DE
)
STIPULATION of Dismissal by Vifor Fresenius Medical Care Renal Pharma France S.A.S., Vifor Fresenius Medical Care Renal Pharma Ltd.. (Farnan, Michael) (Entered: 02/06/2023)